Evidence map›Paper›PMID 39138662›Full record

ArticleHerz2025

Evaluation of risk factors for long-term atrial fibrillation development in patients undergoing typical atrial flutter ablation: a multicenter pilot study.

Ahmet Çağdaş Yumurtaş, Levent Pay, Ozan Tezen, Tuğba Çetin, Furkan Fatih Yücedağ, Ertan Arter, Hikmet Kadıoğlu, Hüseyin Akgün, Eyüp Özkan, Abdulkadir Uslu and 4 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Herz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Sleep duration, blood pressure and cardiovascular outcomes in the middle-aged and the elderly.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ahmet Çağdaş YumurtaşDepartment of Cardiology, Kars Harakani State Hospital, Kars, Turkey. ayumurtas@hotmail.com.ORCID http://orcid.org/0000-0002-7311-2826
Levent PayDepartment of Cardiology, Ardahan State Hospital, Ardahan, Turkey.ORCID http://orcid.org/0000-0002-7491-8119
Ozan TezenDepartment of Cardiology, Bayrampaşa State Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-2774-8348
Tuğba ÇetinDepartment of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-8555-988X
Furkan Fatih YücedağDepartment of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-6732-6521
Ertan ArterDepartment of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0009-0001-1946-1750
Hikmet KadıoğluDepartment of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-8965-8663
Hüseyin AkgünDepartment of Cardiology, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.ORCID http://orcid.org/0009-0001-6744-1287
Eyüp ÖzkanDepartment of Cardiology, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-0792-628X
Abdulkadir UsluDepartment of Cardiology, Kartal Koşuyolu Heart and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-7841-7952
Ayhan KüpDepartment of Cardiology, Kartal Koşuyolu Heart and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-5969-8402
Faysal ŞaylıkDepartment of Cardiology, Van Traning and Research Hospital, Van, Turkey.ORCID http://orcid.org/0000-0003-3165-6769
Tufan ÇınarDepartment of Internal Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-8188-5020
Mert İlker HayıroğluDepartment of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-6515-7349

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial flutter (AFL) and atrial fibrillation (AF) are the most commonly detected supraventricular arrhythmias and share similar pathophysiological mechanisms. After the successful ablation of AFL, AF frequently occurs in the long-term follow-up. As emphasized in some studies, certain mechanisms seem to predispose to the development of AF in AFL patients, and approximately 20% of these patients have accompanying AFL. PURPOSE: We aimed to analyze independent risk factors that predict the development of AF in patients who underwent typical AFL ablation.

methodsThis was a multicenter, cross-sectional, and retrospective study. A total of 442 patients who underwent typical AFL ablation at three different centers between January 1, 2018 and January 1, 2022 were included retrospectively. After the ablation procedure the patients were divided into those who developed AF and those who did not. The patients were followed up for an average of 12 (4-20) months. In the post-procedural period, atrial arrhythmias were investigated with 24‑h Holter and ECG at 1 month, 6 months, and 12 months and then at 6‑month intervals thereafter.

resultsOverall, AF developed in 206 (46.6%) patients in the long-term follow-up. Age, hypertension (HT), obstructive sleep apnea syndrome (OSAS), previous cerebrovascular accident (CVA), left atrium anteroposterior diameter, severe mitral regurgitation, hemoglobin, blood glucose, and HbA1c values were found to be significant in univariable analysis. According to multivariable analysis, HT (p = 0.014; HR: 1.483 [1.084-2.030]), OSAS (p = 0.008; HR: 1.520 [1.117-2.068]) and previous CVA (p = 0.038; HR: 1.749 [1.031-2.968]) were independently associated with the development of AF in AFL patients who underwent ablation procedure.

conclusionIn the present study, we found that HT, OSAS, and previous CVA were independently correlated with the development of AF in the long-term follow-up of patients who underwent typical AFL ablation. We consider that AFL patients with such risk factors should be followed up closely following cavotricuspid isthmus ablation for the development of AF.

Indexed as

Atrial FibrillationAtrial FlutterCatheter AblationPostoperative ComplicationsAgedComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedPilot ProjectsRetrospective StudiesRisk FactorsTreatment OutcomeAblationAtrial fibrillationAtrial flutterCavotricuspid isthmus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.